These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31646476)

  • 1. The second official report from Japanese registry for mechanical assisted circulatory support (J-MACS): first results of bridge to bridge strategy.
    Kinugawa K; Nishimura T; Toda K; Saiki Y; Niinami H; Nunoda S; Matsumiya G; Nishimura M; Arai H; Morita S; Yanase M; Fukushima N; Nakatani T; Sakata Y; Ono M;
    Gen Thorac Cardiovasc Surg; 2020 Feb; 68(2):102-111. PubMed ID: 31646476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-approval study of a highly pulsed, low-shear-rate, continuous-flow, left ventricular assist device, EVAHEART: a Japanese multicenter study using J-MACS.
    Saito S; Yamazaki K; Nishinaka T; Ichihara Y; Ono M; Kyo S; Nishimura T; Nakatani T; Toda K; Sawa Y; Tominaga R; Tanoue T; Saiki Y; Matsui Y; Takemura T; Niinami H; Matsumiya G;
    J Heart Lung Transplant; 2014 Jun; 33(6):599-608. PubMed ID: 24746637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bridge-to-Bridge Left Ventricular Assist Device Implantation Strategy vs. Primary Left Ventricular Assist Device Implantation Strategy.
    Imamura T; Kinugawa K; Ono M; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Matsumiya G; Arai H; Sawa Y
    Circ J; 2020 Nov; 84(12):2198-2204. PubMed ID: 33148939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese registry for Mechanically Assisted Circulatory Support: First report.
    Nakatani T; Sase K; Oshiyama H; Akiyama M; Horie M; Nawata K; Nishinaka T; Tanoue Y; Toda K; Tozawa M; Yamazaki S; Yanase M; Ohtsu H; Ishida M; Hiramatsu A; Ishii K; Kitamura S;
    J Heart Lung Transplant; 2017 Oct; 36(10):1087-1096. PubMed ID: 28942783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of bridge-to-bridge strategies from paracorporeal to implantable left ventricular assist devices on the pre-heart transplant outcome: A single-center analysis of 134 cases.
    Nakajima Doi S; Seguchi O; Yamamoto M; Fujita T; Fukushima S; Mochizuki H; Iwasaki K; Kimura Y; Toda K; Kumai Y; Kuroda K; Watanabe T; Yanase M; Kobayashi J; Kimura T; Fukushima N
    J Cardiol; 2021 Apr; 77(4):408-416. PubMed ID: 33243529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bridge to bridge surgery;conversion from extracorporeal left ventricular assist device to implantable left ventricular assist device].
    Kinoshita O; Ono M
    Kyobu Geka; 2013 Jul; 66(8 Suppl):690-5. PubMed ID: 23917187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm outcome of implantable left ventricular assist devices as a bridge to transplantation: Single-center experience in Japan.
    Kimura M; Kinoshita O; Nawata K; Nishimura T; Hatano M; Imamura T; Endo M; Kagami Y; Kubo H; Kashiwa K; Kinugawa K; Kyo S; Komuro I; Ono M
    J Cardiol; 2015 May; 65(5):383-9. PubMed ID: 25034705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemocompatibility-related Adverse Events Following HeartMate II Left Ventricular Assist Device Implantation between Japan and United States.
    Imamura T; Ono M; Kinugawa K; Fukushima N; Shiose A; Matsui Y; Yamazaki K; Saiki Y; Usui A; Niinami H; Matsumiya G; Arai H; Sawa Y; Uriel N
    Medicina (Kaunas); 2020 Mar; 56(3):. PubMed ID: 32183082
    [No Abstract]   [Full Text] [Related]  

  • 10. Third Annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) Report: Preimplant Characteristics and Outcomes.
    Morales DLS; Rossano JW; VanderPluym C; Lorts A; Cantor R; St Louis JD; Koeh D; Sutcliffe DL; Adachi I; Kirklin JK; Rosenthal DN; Blume ED;
    Ann Thorac Surg; 2019 Apr; 107(4):993-1004. PubMed ID: 30817920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Jarvik 2000 left ventricular assist device as a bridge to transplantation: Japanese Registry for Mechanically Assisted Circulatory Support.
    Kohno H; Matsumiya G; Sawa Y; Ono M; Saiki Y; Shiose A; Yamazaki K; Matsui Y; Niinami H; Matsuda H; Kitamura S; Nakatani T; Kyo S
    J Heart Lung Transplant; 2018 Jan; 37(1):71-78. PubMed ID: 29129374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
    Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
    J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-center experience of the bridge-to-bridge strategy using the Nipro paracorporeal ventricular assist device.
    Yoshitake S; Kinoshita O; Nawata K; Hoshino Y; Itoda Y; Kimura M; Yamauchi H; Ono M
    J Artif Organs; 2018 Dec; 21(4):405-411. PubMed ID: 29943370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second annual Pediatric Interagency Registry for Mechanical Circulatory Support (Pedimacs) report: Pre-implant characteristics and outcomes.
    Blume ED; VanderPluym C; Lorts A; Baldwin JT; Rossano JW; Morales DLS; Cantor RS; Miller MA; St Louis JD; Koehl D; Sutcliffe DL; Eghtesady P; Kirklin JK; Rosenthal DN;
    J Heart Lung Transplant; 2018 Jan; 37(1):38-45. PubMed ID: 28965736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and Safety of the Impella 5.0 as a Bridge to Cardiac Transplantation or Durable Left Ventricular Assist Device.
    Lima B; Kale P; Gonzalez-Stawinski GV; Kuiper JJ; Carey S; Hall SA
    Am J Cardiol; 2016 May; 117(10):1622-1628. PubMed ID: 27061705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of children implanted with ventricular assist devices in the United States: First analysis of the Pediatric Interagency Registry for Mechanical Circulatory Support (PediMACS).
    Blume ED; Rosenthal DN; Rossano JW; Baldwin JT; Eghtesady P; Morales DL; Cantor RS; Conway J; Lorts A; Almond CS; Naftel DC; Kirklin JK;
    J Heart Lung Transplant; 2016 May; 35(5):578-84. PubMed ID: 27009673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DuraHeart™ magnetically levitated left ventricular assist device: Osaka University experience.
    Sakaguchi T; Matsumiya G; Yoshioka D; Miyagawa S; Nishi H; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Sawa Y
    Circ J; 2013; 77(7):1736-41. PubMed ID: 23595087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.